DM Bio

DM Bio is a biopharmaceutical company specializing in the development and manufacturing of mammalian cell culture based therapeutic proteins and monoclonal antibodies. It applies hybrid system to increase production output and QbD/PAT to control quality. DM Bio is a joint venture of Dong-A Socio Holdings and Meiji Seika Pharma.